1. Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial. Issue 1 (January 2023) Authors: Aix, Santiago Ponce; Ciuleanu, Tudor Eliade; Navarro, Alejandro; Cousin, Sophie; Bonanno, Laura; Smit, Egbert F; Chiappori, Alberto; Olmedo, Maria Eugenia; Horvath, Ildiko; Grohé, Christian; Farago, Anna F; López-Vilariño, José Antonio; Cullell-Young, Martin; Nieto, Antonio; Vasco, Noelia; Gómez,... Journal: Lancet Issue: Volume 11:Issue 1(2023) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗